Get More Information on Lung Cancer Surgery Market - Request Sample Report
The Lung Cancer Surgery Market Size was valued at USD 5.4 billion in 2023 and is expected to reach USD 7.9 billion by 2032 and grow at a CAGR of 4.3% over the global forecast period of 2024-2032.
The lung cancer surgery market has soared significantly during the past couple of years, primarily with contributions from advancements in medical technology, growing awareness towards early detection, and improvement in healthcare infrastructure. So far, surgical intervention remains the most viable treatment alternative for patients with lung cancer who, depending on the extent of their illness, are within the operational limitations of having localized tumors or those who can benefit from surgical intervention. Lobectomy, pneumonectomy, or more recent methods such as video-assisted thoracic surgery of these procedures have become very popular in years because they can reduce postoperative complications and serve to contribute to quick recovery. According to the Global Cancer Observatory, lung cancer ranked as the second most commonly diagnosed cancer in 2020, with a total of 2,206,771 new cases. It was also the leading cause of cancer-related mortality, resulting in 1,796,144 deaths.
Robotic surgery is one of the advancements that continue to emerge in lung cancer surgery. These systems offer magnification and enhanced precision to surgeons thus allowing them to decrease large incisions and, hence good patient outcomes. For example, the Temple University Hospital recently introduced the Ion endoluminal system using robotic technology to reach lung nodules for biopsy, allowing better mobility and navigation through narrow airways. Further emphasis on this trend is coming from other industry participants as well, who are constantly developing advanced robotic surgery platforms, like Medtronic's Hugo RAS system, which supports the efficient completion of soft tissue surgeries.
New technologies for imaging, such as cone-beam CT and augmented fluoroscopy, push the market forward by making surgical procedures more precise and less dependent on costly surgical devices. Such technology enables seeing into the details of the procedure, thus improving the outcome for the patient.
Geographically, the market for lung cancer surgery is heavily reliant on healthcare spending, cancer prevalence, and the availability of highly advanced medical facilities. Developed regions, having well-established healthcare infrastructure and more significant developments in the adoption of modern surgical practices, are directing their focus toward making improvements in their infrastructure for lung cancer diagnosis and treatment. This global effort will, in turn, accelerate the growth of the lung cancer surgery market in the years to come.
Drivers
The increasing incidence of lung cancer is the major factor affecting the growth of the worldwide lung cancer surgery market. As the number of diagnosed cases is rising, both minimally invasive and traditional open surgeries are being sought on a large scale. In 2020, WHO states that around 18% of the total cancer deaths were due to lung cancer, accounting for 1.8 million deaths. This rising incidence, in turn, fuels the need for surgical interventions immediately. Product innovations and launches are also the market growth drivers. For instance, in September 2020, Koninklijke Philips N.V. unveiled Azurion Lung Edition, a 3D imaging and navigation platform that significantly enhances lung cancer diagnosis and treatment. Combining CT-like 3D images with live X-ray guidance, accelerates and improves the precision of lung cancer procedures, thereby fueling up the demand in the market.
Early detection has been key in altering survival trends of this deadly cancer, lung cancer. Curative therapy of lung cancer in its early stages depends greatly on surgical interventions. For instance, a new AI-based tool called Sybil which was developed by MIT researchers alongside those from Mass General Cancer Center reportedly had the capability of being able to predict lung cancer development with an accuracy level of 86% to 94% in 2023. The market is also propelled forward by partnerships and collaborations. An example here would be the August 2023 joint development agreement with Silicon & Software Systems Ltd. in the development of a device for the detection and monitoring of lung cancer by VOCxi Health, an industry that is keen on broadening the frontiers of diagnostics through strategic alliances.
Restraints
Elevated Expenses Associated with Lung Cancer Surgery
Post-Surgical Complications in Lung Cancer Treatment
Limited Awareness in Developing Regions
By Product Type:
The Robotic-Assisted Thoracic Surgery Systems was the dominating lung cancer surgery segment in 2023 with a market share of 23.4%, primarily due to the increasing adoption of high precision and low invasiveness offered by these robotic platforms and improved patient outcomes. These systems are used over conventional surgical instruments as they bring in lesser need for large incisions and better visualization for complex procedures. The Monitoring & Visualizing System segment will be growing at the fastest pace as imaging-related technology advances, like increased surgical accuracy with fewer complications in the use of augmented fluoroscopy and cone-beam CT.
By Surgery Type:
Minimally Invasive Surgery was the leading segment in the market with a 67.1% share in 2023, with the adoption of video-assisted thoracic surgery, among others, in preference to increased benefits, such as lower postoperative complications and quicker recovery times. This segment is also growing rapidly with the introduction of robotic systems in surgery, furthering the reductions in invasiveness. On the other hand, Open Surgery is still needed for more complicated cases as it requires larger resections; however, the rate of growth is relatively slower.
By Procedure:
Lobectomy held the largest market share, considering its common usage. It topped this segment in 2023 with a share of 20.5%. Lobectomy is considered the gold standard for the treatment of early-stage lung cancer and has the best survival rates. The Segmentectomy/Wedge Resection segment is expected to witness the most rapid growth because the less invasive procedure is gaining the maximum prominence for patients with small or localized tumors or with limited lung capacity.
By Cancer Stage:
The Early-Stage category accounted for the majority share of the market, 62.3% in 2023, as surgery remains the primary mode of treatment for patients diagnosed with lung cancer in early stages where the tumor is localized and has not spread. The advanced stage is likely to have a higher growth rate because late-stage diagnoses are on the increase, as are improvements in surgical techniques, which allow the surgeon to resect greater complex tissues in advanced-stage cancer cases.
By End-user:
In 2023, hospitals led the market with 42.1% because they can accommodate more complex lung cancer surgery, especially when advanced imaging and robotic systems are used. The infrastructural facilities and trained professionals are available in hospitals for open as well as minimally invasive surgeries. However, ASCs are increasing at the fastest rate because more patients opt for outpatient departments for the operation, considering a reduced cost, lesser stay, and quick recovery.
North America dominated with 33.5% in 2023. This is because the region, especially the U.S. and Canada, boasts strong healthcare foundations and surgical technological capabilities. The key will be on minimally invasive surgeries like VATS (video-assisted thoracoscopic surgery) and robotic-assisted surgery, as well as faster recovery times and fewer postoperative complications. In North America, research and development in an attempt to bring forth more individualized approaches to treatment have also meant better patient outcomes.
Lung cancer surgery market Europe is the second largest lung cancer surgery market, accounting for more than 26.1% of the total share in 2023. European countries have always been at the forefront of adopting innovative surgical techniques for treating lung cancer. The region focuses on treatment through multidisciplinary care, including surgery, chemotherapy, and radiotherapy, to heighten the possibility of recovery. There are specialized cancer centers, well-integrated health care, and a smoothly working system that facilitates adopting advanced surgical procedures across the region.
Asia Pacific has emerged as the market with the highest growth rate, with a share of more than 20.3% in 2023. The lung cancer surgery market is growing in China, Japan, and South Korea. The aforementioned factors are also spurred by the growing smoking population and improved healthcare infrastructure. Above all, awareness about cancer's early detection has helped build traction in the market. Investments in health information technology and infrastructure have fueled this upward trend in the adoption of lung cancer surgeries, but of late, there has been a shift in the trend toward the adoption of more minimally invasive procedures in the region.
Need any customization research on Lung Cancer Surgery Market - Enquiry Now
Accuray Incorporated (CyberKnife System)
GE Healthcare (Revolution CT Scanner)
Johnson and Johnson (Harmonic Scalpel)
Olympus Corporation (BF-1TQ160 Bronchoscope, PNT Series Endobronchial Ultrasound (EBUS))
Siemens Healthineers AG (Biograph Horizon, Acuson S2000)
Ethicon Endo Surgery Inc. (Ethicon Endo-Surgery Harmonic Products)
Richard Wolf GMBH (Lung Surgery Instruments)
Scanlan International Inc. (Thoracic Surgical Instruments)
Angiodynamics (OncoSecure Port System)
Neomend Inc. (NeoBond and NeoPatch)
Trokamed GMBH (Thoracic Surgery Instruments)
Covidien (Endo GIA Staplers, Ligasure Devices)
BSD Medical Corp. (BSD-2000 System) and others.
In February 2023, Intuitive Surgical Inc., a leading developer and manufacturer of medical products for healthcare providers, acquired Auris Health Inc., a medical device company specializing in robotic-assisted bronchoscopy systems. This acquisition provides Intuitive Surgical with a new platform to further advance its development of robotic-assisted systems for lung cancer surgeries.
In April 2023, Medtronic announced the launch of its Hugo robotic-assisted surgery (RAS) system in additional markets, expanding its reach for thoracic surgeries, including lung cancer surgeries. This move further strengthens Medtronic's position in the robotic surgery market by offering minimally invasive solutions with enhanced precision.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 5.4 billion |
| Market Size by 2032 | US$ 7.9 billion |
| CAGR | CAGR of 4.3% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems, Others) • By Surgery Type (Open Surgery, Minimally Invasive Surgery) • By Procedure (Lobectomy, Segmentectomy/Wedge Resection, Pneumonectomy, Sleeve Resection, Extended Resection) • By Cancer Stage (Early-Stage, Advanced-Stage) • By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation, Siemens Healthineers AG, Ethicon Endo Surgery Inc., Richard Wolf GMBH, Scanlan International Inc., Angiodynamics, Neomend Inc., Trokamed GMBH, Covidien, BSD Medical Corp and others. |
| Key Drivers | • Rising Incidence, Innovation, and Early Detection |
| Market Restraints | • Elevated Expenses Associated with Lung Cancer Surgery • Post-Surgical Complications in Lung Cancer Treatment • Limited Awareness in Developing Regions |
Ans: The estimated compound annual growth rate is 4.3% during the forecast period for the Lung Cancer Surgery market.
Ans: The projected market value of the Lung Cancer Surgery market is estimated at USD 4.5 billion in 2023 and is expected to reach USD 7.9 billion by 2032.
Ans: The increasing incidence of lung cancer is the major factor affecting the growth of the worldwide lung cancer surgery market.
Ans: Elevated Expenses Associated with Lung Cancer Surgery.
Ans: North America is the dominant region with a 33.5% share in the Lung Cancer Surgery market.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Lung Cancer Surgery Market Segmentation, by Product Type
7.1 Chapter Overview
7.2 Surgical Instruments
7.2.1 Surgical Instruments Market Trends Analysis (2020-2032)
7.2.2 Surgical Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Monitoring & Visualizing System
7.3.1 Monitoring & Visualizing System Market Trends Analysis (2020-2032)
7.3.2 Monitoring & Visualizing System Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Endosurgical Equipment
7.4.1 Endosurgical Equipment Market Trends Analysis (2020-2032)
7.4.2 Endosurgical Equipment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Robotic-Assisted Thoracic Surgery Systems
7.5.1 Robotic-Assisted Thoracic Surgery Systems Market Trends Analysis (2020-2032)
7.5.2 Robotic-Assisted Thoracic Surgery Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Others
7.6.1 Others Market Trends Analysis (2020-2032)
7.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Lung Cancer Surgery Market Segmentation, By Surgery Type
8.1 Chapter Overview
8.2 Open Surgery
8.2.1 Open Surgery Market Trends Analysis (2020-2032)
8.2.2 Open Surgery Market Size Estimates And Forecasts To 2032 (USD Billion)
8.3 Minimally Invasive Surgery
8.3.1 Minimally Invasive Surgery Market Trends Analysis (2020-2032)
8.3.2 Minimally Invasive Surgery Market Size Estimates And Forecasts To 2032 (USD Billion)
9. Lung Cancer Surgery Market Segmentation, By Procedure
9.1 Chapter Overview
9.2 Lobectomy
9.2.1 Lobectomy Market Trends Analysis (2020-2032)
9.2.2 Lobectomy Market Size Estimates And Forecasts To 2032 (USD Billion)
9.3 Segmentectomy/Wedge Resection
9.3.1 Segmentectomy/Wedge Resection Market Trends Analysis (2020-2032)
9.3.2 Segmentectomy/Wedge Resection Market Size Estimates And Forecasts To 2032 (USD Billion)
9.4 Pneumonectomy
9.4.1 Pneumonectomy Market Trends Analysis (2020-2032)
9.4.2 Pneumonectomy Market Size Estimates And Forecasts To 2032 (USD Billion)
9.5 Sleeve Resection
9.5.1 Sleeve Resection Market Trends Analysis (2020-2032)
9.5.2 Sleeve Resection Market Size Estimates And Forecasts To 2032 (USD Billion)
9.6 Extended Resection
9.6.1 Extended Resection Market Trends Analysis (2020-2032)
9.6.2 Extended Resection Market Size Estimates And Forecasts To 2032 (USD Billion)
10. Lung Cancer Surgery Market Segmentation, By Cancer Stage
10.1 Chapter Overview
10.2 Early-Stage
10.2.1 Early-Stage Market Trends Analysis (2020-2032)
10.2.2 Early-Stage Market Size Estimates And Forecasts To 2032 (USD Billion)
10.3 Advanced-Stage
10.3.1 Advanced-Stage Market Trends Analysis (2020-2032)
10.3.2 Advanced-Stage Market Size Estimates And Forecasts To 2032 (USD Billion)
11. Lung Cancer Surgery Market Segmentation, By End-user
11.1 Chapter Overview
11.2 Hospitals
11.2.1 Hospitals Market Trends Analysis (2020-2032)
11.2.2 Hospitals Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3 Ambulatory Surgical Centers
11.3.1 Ambulatory Surgical Centers Market Trends Analysis (2020-2032)
11.3.2 Ambulatory Surgical Centers Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4 Specialty Clinics
11.4.1 Specialty Clinics Market Trends Analysis (2020-2032)
11.4.2 Specialty Clinics Market Size Estimates And Forecasts To 2032 (USD Billion)
12. Regional Analysis
12.1 Chapter Overview
12.2 North America
12.2.1 Trends Analysis
12.2.2 North America Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.2.3 North America Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.2.4 North America Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.2.5 North America Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.2.6 North America Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.2.7 North America Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.2.8 USA
12.2.8.1 USA Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.2.8.2 USA Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.2.8.3 USA Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.2.8.4 USA Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.2.8.5 USA Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.2.9 Canada
12.2.9.1 Canada Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.2.9.2 Canada Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.2.9.3 Canada Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.2.9.4 Canada Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.2.9.5 Canada Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.2.10 Mexico
12.2.10.1 Mexico Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.2.10.2 Mexico Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.2.10.3 Mexico Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.2.10.4 Mexico Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.2.10.5 Mexico Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Trends Analysis
12.3.1.2 Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.3.1.3 Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.1.4 Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.1.5 Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.1.6 Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.1.7 Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.1.8 Poland
12.3.1.8.1 Poland Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.1.8.2 Poland Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.1.8.3 Poland Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.1.8.4 Poland Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.1.8.5 Poland Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.1.9 Romania
12.3.1.9.1 Romania Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.1.9.2 Romania Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.1.9.3 Romania Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.1.9.4 Romania Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.1.9.5 Romania Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.1.10 Hungary
12.3.1.10.1 Hungary Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.1.10.2 Hungary Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.1.10.3 Hungary Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032)(USD Billion)
12.3.1.10.4 Hungary Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.1.10.5 Hungary Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.1.11 Turkey
12.3.1.11.1 Turkey Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.1.11.2 Turkey Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.1.11.3 Turkey Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.1.11.4 Turkey Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.1.11.5 Turkey Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.1.12 Rest Of Eastern Europe
12.3.1.12.1 Rest Of Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.1.12.2 Rest Of Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.1.12.3 Rest Of Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.1.12.4 Rest Of Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.1.12.5 Rest Of Eastern Europe Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2 Western Europe
12.3.2.1 Trends Analysis
12.3.2.2 Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.3.2.3 Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.4 Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.5 Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.6 Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.7 Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.8 Germany
12.3.2.8.1 Germany Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.8.2 Germany Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.8.3 Germany Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.8.4 Germany Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.8.5 Germany Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.9 France
12.3.2.9.1 France Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.9.2 France Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.9.3 France Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.9.4 France Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.9.5 France Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.10 UK
12.3.2.10.1 UK Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.10.2 UK Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.10.3 UK Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.10.4 UK Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.10.5 UK Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.11 Italy
12.3.2.11.1 Italy Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.11.2 Italy Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.11.3 Italy Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.11.4 Italy Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.11.5 Italy Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.12 Spain
12.3.2.12.1 Spain Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.12.2 Spain Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.12.3 Spain Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.12.4 Spain Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.12.5 Spain Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.13 Netherlands
12.3.2.13.1 Netherlands Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.13.2 Netherlands Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.13.3 Netherlands Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.13.4 Netherlands Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.13.5 Netherlands Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.14 Switzerland
12.3.2.14.1 Switzerland Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.14.2 Switzerland Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.14.3 Switzerland Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.14.4 Switzerland Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.12.5 Switzerland Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.15 Austria
12.3.2.15.1 Austria Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.15.2 Austria Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.15.3 Austria Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.15.4 Austria Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.15.5 Austria Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.3.2.16 Rest Of Western Europe
12.3.2.16.1 Rest Of Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.3.2.16.2 Rest Of Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.3.2.16.3 Rest Of Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.3.2.16.4 Rest Of Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.3.2.16.5 Rest Of Western Europe Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4 Asia Pacific
12.4.1 Trends Analysis
12.4.2 Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.4.3 Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.4 Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.5 Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.6 Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.7 Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.8 China
12.4.8.1 China Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.8.2 China Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.8.3 China Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.8.4 China Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.8.5 China Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.9 India
12.4.9.1 India Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.9.2 India Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.9.3 India Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.9.4 India Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.9.5 India Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.10 Japan
12.4.10.1 Japan Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.10.2 Japan Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.10.3 Japan Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.10.4 Japan Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.10.5 Japan Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.11 South Korea
12.4.11.1 South Korea Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.11.2 South Korea Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.11.3 South Korea Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.11.4 South Korea Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.11.5 South Korea Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.12 Vietnam
12.4.12.1 Vietnam Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.12.2 Vietnam Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.12.3 Vietnam Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.12.4 Vietnam Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.12.5 Vietnam Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.13 Singapore
12.4.13.1 Singapore Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.13.2 Singapore Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.13.3 Singapore Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.13.4 Singapore Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.13.5 Singapore Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.14 Australia
12.4.14.1 Australia Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.14.2 Australia Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.14.3 Australia Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.14.4 Australia Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.14.5 Australia Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.4.15 Rest Of Asia Pacific
12.4.15.1 Rest Of Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.4.15.2 Rest Of Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.4.15.3 Rest Of Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.4.15.4 Rest Of Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.4.15.5 Rest Of Asia Pacific Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5 Middle East And Africa
12.5.1 Middle East
12.5.1.1 Trends Analysis
12.5.1.2 Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.5.1.3 Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.1.4 Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.5.1.5 Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.1.6 Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.1.7 Middle East Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.1.8 UAE
12.5.1.8.1 UAE Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.1.8.2 UAE Lung Cancer Surgery Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.5.1.8.3 UAE Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.1.8.4 UAE Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.1.8.5 UAE Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.1.9 Egypt
12.5.1.9.1 Egypt Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.1.9.2 Egypt Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.1.9.3 Egypt Lung Cancer Surgery Market Estimates And Forecasts, By Procedure(2020-2032) (USD Billion)
12.5.1.9.4 Egypt Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.1.9.5 Egypt Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.1.10 Saudi Arabia
12.5.1.10.1 Saudi Arabia Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.1.10.2 Saudi Arabia Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.1.10.3 Saudi Arabia Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.1.10.4 Saudi Arabia Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.1.10.5 Saudi Arabia Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.1.11 Qatar
12.5.1.11.1 Qatar Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.1.11.2 Qatar Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.1.11.3 Qatar Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.1.11.4 Qatar Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.1.11.5 Qatar Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.1.12 Rest Of Middle East
12.5.1.12.1 Rest Of Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.1.12.2 Rest Of Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.1.12.3 Rest Of Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.1.12.4 Rest Of Middle East Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.1.12.5 Rest Of Middle East Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.2 Africa
12.5.2.1 Trends Analysis
12.5.2.2 Africa Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.5.2.3 Africa Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.2.4 Africa Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.2.5 Africa Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.2.6 Africa Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.2.7 Africa Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.2.8 South Africa
12.5.2.8.1 South Africa Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.2.8.2 South Africa Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.2.8.3 South Africa Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.2.8.4 South Africa Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.2.8.5 South Africa Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.2.9 Nigeria
12.5.2.9.1 Nigeria Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.2.9.2 Nigeria Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.2.9.3 Nigeria Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.2.9.4 Nigeria Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.2.9.5 Nigeria Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.5.2.10 Rest Of Africa
12.5.2.10.1 Rest Of Africa Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.5.2.10.2 Rest Of Africa Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.5.2.10.3 Rest Of Africa Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.5.2.10.4 Rest Of Africa Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.5.2.10.5 Rest Of Africa Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.6 Latin America
12.6.1 Trends Analysis
12.6.2 Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.6.3 Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.6.4 Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.6.5 Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.6.6 Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.6.7 Latin America Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.6.8 Brazil
12.6.8.1 Brazil Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.6.8.2 Brazil Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.6.8.3 Brazil Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.6.8.4 Brazil Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.6.8.5 Brazil Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.6.9 Argentina
12.6.9.1 Argentina Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.6.9.2 Argentina Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.6.9.3 Argentina Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.6.9.4 Argentina Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.6.9.5 Argentina Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.6.10 Colombia
12.6.10.1 Colombia Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.6.10.2 Colombia Lung Cancer Surgery Market Estimates And Forecasts, By Surgery Type (2020-2032) (USD Billion)
12.6.10.3 Colombia Lung Cancer Surgery Market Estimates And Forecasts, By Procedure (2020-2032) (USD Billion)
12.6.10.4 Colombia Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.6.10.5 Colombia Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
12.6.11 Rest Of Latin America
12.6.11.1 Rest Of Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Product Type (2020-2032) (USD Billion)
12.6.11.2 Rest Of Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.6.11.3 Rest Of Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Procedure(2020-2032) (USD Billion)
12.6.11.4 Rest Of Latin America Lung Cancer Surgery Market Estimates And Forecasts, By Cancer Stage (2020-2032) (USD Billion)
12.6.11.5 Rest Of Latin America Lung Cancer Surgery Market Estimates And Forecasts, By End-user (2020-2032) (USD Billion)
13. Company Profiles
13.1 Accuray Incorporated
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.2 GE Healthcare
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.3 Johnson and Johnson
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.4 Olympus Corporation
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.5 Siemens Healthineers AG
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.6 Ethicon Endo Surgery Inc.
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.7 Richard Wolf GMBH
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.8 Scanlan International Inc.
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.9 Angiodynamics
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.10 Neomend Inc.
13.12.1 Company Overview
13.12.2 Financial
13.12.3 Products/ Services Offered
13.12.4 SWOT Analysis
14. Use Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Product Type:
Surgical Instruments
Monitoring & Visualizing System
Endosurgical Equipment
Robotic-Assisted Thoracic Surgery Systems
Others
By Surgery Type:
Open Surgery
Minimally Invasive Surgery
By Procedure:
Lobectomy
Segmentectomy/Wedge Resection
Pneumonectomy
Sleeve Resection
Extended Resection
By Cancer Stage:
Early-Stage
Advanced-Stage
By End-user:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Autism Spectrum Disorder Treatment Market size was valued at USD 2.16 Billion in 2023 and is expected to reach USD 3.71 Billion By 2032 and grow at a CAGR of 6.2% over the forecast period of 2024-2032.
The Anesthesia Drugs Market Size was valued at USD 5.9 billion in 2023 & is expected to reach USD 8.6 billion by 2032 with a growing CAGR of 4.2% over the forecast period of 2024-2032.
The Dermatology Devices Market Size was valued at USD 8.94 billion in 2023, and is expected to reach USD 21.06 billion by 2031, and grow at a CAGR of 11.92% over the forecast period 2024-2031.
The Medical Clothing Market, valued at USD 110 Billion in 2023, The Medical Clothing Market valued USD 85.95 Billion in 2023 and anticipated to reach USD 163.84 billion by 2032 with compound annual growth rate 7.45% over the forecast period 2024-2032.
The Psoriatic Arthritis Treatment Market size was USD 9.97 Billion in 2023 and is expected to Reach USD 24.87 Billion by 2031 and grow at a CAGR of 12.1% over the forecast period of 2024-2031.
The Blood Glucose Monitoring Device Market Size was valued at USD 13.42 billion in 2023, and is expected to reach USD 25.28 billion by 2031, and grow at a CAGR of 8.24% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
